MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Malpractice Risk
20 questions · exam conditions
0:00
Malpractice RiskQuestion 1 of 20

A pharmacist is named in a malpractice lawsuit. She has professional liability (malpractice) insurance. What is the PRIMARY benefit of this coverage in this situation?

It prevents the state board from taking disciplinary action
It covers legal defense costs and any damages awarded up to the policy limit
It indemnifies the employer against all claims arising from the pharmacist's employment
It satisfies the DEA's requirement for registered pharmacists to carry liability coverage
← Back to quizzes

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz

MPJE: Multistate Pharmacy Jurisprudence Examination Quiz: Malpractice Risk

Practice Malpractice Risk in MPJE: Multistate Pharmacy Jurisprudence Examination with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Malpractice Risk, giving you a quick way to practice the rules, question types, and explanations that matter most for MPJE: Multistate Pharmacy Jurisprudence Examination.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A pharmacist is named in a malpractice lawsuit. She has professional liability (malpractice) insurance. What is the PRIMARY benefit of this coverage in this situation?

  1. It prevents the state board from taking disciplinary action
  2. It covers legal defense costs and any damages awarded up to the policy limit (correct answer)
  3. It indemnifies the employer against all claims arising from the pharmacist's employment
  4. It satisfies the DEA's requirement for registered pharmacists to carry liability coverage
Explanation: Professional liability insurance covers the insured pharmacist's legal defense costs and indemnifies against damages awarded within the policy limits. It does not protect against state board disciplinary proceedings, which are separate regulatory actions. The policy covers the individual pharmacist, not necessarily the employer. The DEA does not require liability insurance as a condition of registration.

Question 2

A pharmacist fails to counsel a patient about a serious drug interaction and the patient is hospitalized. Which malpractice risk-reduction practice would have MOST directly prevented this harm?

  1. Requiring a second pharmacist to sign off on all dispensed prescriptions
  2. Conducting prospective drug utilization review (DUR) and offering counseling as required under OBRA '90 (correct answer)
  3. Filing a MedWatch report with the FDA after the interaction occurs
  4. Documenting the patient's insurance information in the pharmacy record
Explanation: OBRA '90 requires pharmacists to perform prospective DUR and offer counseling on new prescriptions. Identifying a drug interaction during DUR and counseling the patient are direct prevention measures. A dual-verification requirement addresses dispensing accuracy but not DUR/counseling. MedWatch is a post-event reporting mechanism, not a preventive one. Insurance documentation is administrative and does not prevent clinical harm.

Question 3

A compounding pharmacy prepares a sterile ophthalmic preparation that is later found to contain particulate matter. Several patients suffer eye injuries. Which legal theory would MOST likely support strict liability claims against the pharmacy?

  1. Negligence per se based on violation of USP 797 standards
  2. Strict products liability for distributing a defective compounded product. (correct answer)
  3. Respondeat superior holding the pharmacist liable for technician errors
  4. Contributory negligence based on the prescriber's off-label use request
Explanation: In jurisdictions that apply strict products liability to pharmacy-compounded preparations, plaintiffs may bring a defective product claim without needing to prove negligence -- only that the product was defective and caused harm. Whether strict products liability applies to a compounding pharmacy varies by state; some states treat pharmacy compounding as a professional service not subject to strict products liability, while others apply it. Among the choices, products liability is the theory most directly aligned with the described harm from a defective preparation. Negligence per se requires an underlying statutory violation as its basis and is not a strict liability theory. Respondeat superior addresses employer/employee liability for an employee's tortious acts, not product defects. Contributory negligence is a defense, not a plaintiff's cause of action.

Question 4

A patient suffers harm from a dispensing error and files a malpractice suit. The pharmacy argues the patient's own failure to read the medication guide contributed to the injury. This defense is known as:

  1. Respondeat superior
  2. Res ipsa loquitur
  3. Comparative or contributory negligence (correct answer)
  4. Assumption of risk
Explanation: Comparative negligence (in most states) and contributory negligence (in a minority of states) are defenses that reduce or eliminate a defendant's liability when the plaintiff's own negligence contributed to the harm. Arguing that the patient failed to read available safety information may support this defense. Respondeat superior establishes employer liability. Res ipsa loquitur infers negligence from circumstances. Assumption of risk involves knowingly accepting a known danger.

Question 5

A hospital pharmacist prepares a chemotherapy infusion with a 10-fold overdose due to a calculation error. The patient dies. Which factor would MOST increase the pharmacy's malpractice exposure in this case?

  1. The patient had a terminal diagnosis prior to the chemotherapy
  2. The error was made by a technician rather than a pharmacist
  3. The pharmacy did not carry professional liability insurance
  4. The pharmacy lacked a required double-check process for high-alert medication preparation (correct answer)
Explanation: High-alert medications like chemotherapy require independent double-checks as part of the recognized standard of care. The absence of a required double-check process indicates both a system failure and a deviation from standard practice, significantly increasing liability. A terminal diagnosis does not eliminate liability for errors that hasten death. Technician error does not shield the pharmacist or institution from respondeat superior liability. Lack of insurance affects recovery, not the underlying liability.

Question 6

A pharmacist receives a prescription for warfarin 10 mg daily - an unusually high dose. The pharmacist dispenses without verifying with the prescriber. The patient experiences a severe bleeding event. What best describes the pharmacist's liability?

  1. No liability because the prescriber bears sole responsibility for the dose
  2. No liability because the pharmacist followed the written prescription exactly
  3. Reduced liability because the pharmacist relied on the prescriber's clinical judgment
  4. Potential liability for failing to exercise professional judgment and verify an obviously problematic dose (correct answer)
Explanation: Pharmacists have a professional duty that includes recognizing and acting on clinically significant concerns such as an unusually high dose. Simply filling a prescription as written does not shield the pharmacist from liability when a reasonable pharmacist would have identified the dose as problematic and contacted the prescriber. The doctrine of corresponding responsibility also supports pharmacist liability when filling an apparently erroneous order.

Question 7

A pharmacist receives a verbal order from a nurse for a controlled substance in a hospital setting. The pharmacist dispenses based on the verbal order but fails to document it. The patient later claims the drug was not authorized. Which risk-reduction practice was neglected?

  1. Contemporaneous documentation of the verbal order and follow-up written order (correct answer)
  2. Filing a DEA Form 222 for all verbal controlled substance orders
  3. Obtaining a written prescription from the patient before dispensing
  4. Reporting the verbal order to the FDA's MedWatch system
Explanation: Verbal orders in institutional settings require contemporaneous documentation in the patient's record and a written follow-up order from the prescriber. This documentation establishes an auditable record that protects both the pharmacist and the institution. DEA Form 222 applies to Schedule I/II procurement from suppliers, not individual patient dispensing. Patients do not authorize their own prescriptions. MedWatch is for adverse event reporting, not order documentation.

Question 8

A pharmacist working for an independent pharmacy is also privately employed as a consulting pharmacist for a long-term care facility. If the pharmacist makes a negligent error while consulting at the LTC facility, which employer is MOST likely liable under respondeat superior?

  1. The independent pharmacy, because it holds the pharmacist's primary employment
  2. Both employers equally, regardless of where the error occurred
  3. The LTC facility, as the error occurred during consulting duties. (correct answer)
  4. Neither employer; individual pharmacists bear sole liability for consulting errors
Explanation: Under respondeat superior, the employer whose work the pharmacist was performing at the time of the negligent act is liable. Because the error occurred during the LTC consulting engagement, the LTC facility (or the consulting arrangement's employing entity) bears vicarious liability. The independent pharmacy is not liable for conduct outside its scope of work. Individual pharmacists also retain personal liability, but respondeat superior extends liability to the employer.

Question 9

A pharmacy manager is reviewing causes of dispensing errors over the past year. Most errors involve look-alike/sound-alike (LASA) drug pairs. Which intervention would MOST effectively reduce malpractice risk from LASA errors?

  1. Requiring patients to confirm their diagnoses before picking up prescriptions
  2. Reporting all LASA errors to the DEA as controlled substance incidents
  3. Submitting LASA drug pair data to the FDA's drug shortage database
  4. Implementing physical separation of LASA drugs, tall-man lettering on labels, and barcode verification at dispensing (correct answer)
Explanation: LASA drug errors are best reduced through system-level interventions: physically separating LASA drugs on shelves, using tall-man lettering to highlight distinguishing letters, and barcode scanning to verify the correct product. These directly address the root cause. Patient diagnosis confirmation is impractical and addresses the wrong step. LASA errors are not DEA reporting events unless controlled substances are involved in a loss. FDA drug shortage databases track availability, not dispensing error prevention.

Question 10

A pharmacist makes a dispensing error that causes patient harm. The pharmacy's risk manager initiates an internal incident report. Which statement about incident reports is most accurate from a liability perspective?

  1. Incident reports are always discoverable in civil litigation
  2. Incident reports should never be created because they increase malpractice risk
  3. Incident reports are required to be submitted to the FDA within 15 days
  4. Incident reports are valuable for internal quality improvement; their discoverability in litigation varies by state law (correct answer)
Explanation: Incident reports serve an important internal quality improvement function by capturing error details and enabling systemic fixes. Their discoverability in civil litigation depends on state law - some states provide qualified privilege for peer review and quality improvement documents. They are not categorically discoverable or categorically protected. FDA 15-day reports apply to serious adverse drug events, not pharmacy dispensing errors. Creating incident reports is standard risk management practice.

Question 11

A retail pharmacist notices a patient picking up a prescription for lithium appears confused and is asking questions suggesting she may not understand the medication. The pharmacist dismisses the patient quickly due to high store volume. The patient later experiences a toxic lithium level. What risk management principle did the pharmacist violate?

  1. The pharmacist violated USP 800 requirements for hazardous drug handling
  2. The pharmacist failed to provide required patient counseling on medication use. (correct answer)
  3. The pharmacist violated HIPAA by not documenting the patient interaction
  4. The pharmacist violated DEA regulations by dispensing lithium without verification
Explanation: A pharmacist's professional duty to counsel -- particularly when a patient appears confused about a high-risk, narrow-therapeutic-index medication such as lithium -- is a recognized standard of care whose breach increases malpractice risk. This duty derives primarily from state pharmacy practice acts and professional standards. Note that OBRA '90 required Medicaid pharmacies to offer counseling to Medicaid patients as a condition of Medicaid reimbursement; most states have since enacted counseling requirements in their pharmacy practice acts that extend to all retail patients. Dismissing a patient who appears confused about a drug with a narrow therapeutic index breaches the applicable standard of care. A is incorrect because USP 800 governs hazardous drug handling and lithium is not classified as a hazardous drug under NIOSH criteria. C is incorrect because HIPAA governs privacy of health information and does not require counseling documentation in this context. D is incorrect because lithium is not a controlled substance and DEA regulations do not govern its dispensing.

Question 12

A pharmacist counsels a patient about a new anticoagulant and documents the counseling in the pharmacy record. Three months later, the patient claims they were never told about bleeding risks. The documentation serves which primary purpose in litigation?

  1. It demonstrates compliance with counseling standards, aiding in legal defense. (correct answer)
  2. It automatically bars the patient from filing a malpractice claim
  3. It transfers liability from the pharmacist to the prescriber
  4. It satisfies FDA documentation requirements for anticoagulant counseling
Explanation: Contemporaneous documentation of counseling activities is one of the most effective defenses in malpractice litigation. If the record shows the pharmacist counseled the patient about bleeding risks, this evidence supports that the standard of care was met. Documentation does not bar claims entirely, does not transfer liability to the prescriber, and no specific FDA documentation requirement governs anticoagulant counseling in a retail setting.

Question 13

A pharmacist correctly fills a prescription but places it in a bag with another patient's medication. The wrong patient takes home the other patient's prescription. No harm results, but the error is discovered. What is the pharmacist's BEST course of action?

  1. Take no action since no harm occurred
  2. Only document the error internally and do not contact the patients
  3. Report the error to the DEA as a controlled substance loss
  4. Inform both patients, correct the error, and document the incident. (correct answer)
Explanation: Even when no immediate harm results, best practice and ethical obligation require notifying affected patients, correcting the error (retrieving misdirected medications, ensuring patients have the correct ones), and documenting the incident for quality improvement. This approach is consistent with the standard of care and transparency principles. Inaction after an identified error - even a non-harmful one - is not appropriate. The error is not a DEA reporting event unless controlled substances were involved in a loss or theft.

Question 14

Which legal doctrine holds a pharmacy employer liable for a pharmacist employee's negligent acts committed within the scope of employment?

  1. Res ipsa loquitur
  2. Contributory negligence
  3. Respondeat superior (correct answer)
  4. Assumption of risk
Explanation: Respondeat superior ('let the master answer') holds employers vicariously liable for negligent acts of employees performed within the scope of their employment. Res ipsa loquitur infers negligence from the circumstances of an injury. Contributory negligence involves the plaintiff's own fault. Assumption of risk is a defense based on the plaintiff knowingly accepting a risk.

Question 15

A pharmacist dispenses metformin instead of methotrexate due to a picking error. The patient suffers harm. To succeed in a negligence claim, the patient must prove which four elements?

  1. Duty, breach of duty, causation, and damages (correct answer)
  2. Intent, knowledge, foreseeability, and injury
  3. Licensure, deviation, recklessness, and harm
  4. Standard of care, oversight, proximate cause, and restitution
Explanation: A negligence claim requires the plaintiff to establish: (1) the defendant owed a duty of care; (2) the defendant breached that duty; (3) the breach caused the plaintiff's injury (causation); and (4) actual damages resulted. The pharmacist-patient relationship establishes duty. Dispensing the wrong drug is a breach. The patient's resulting harm is both the causation link and the damages element.

Question 16

A pharmacy implements a barcode scanning system for all dispensed medications to reduce picking errors. This is an example of which type of malpractice risk management strategy?

  1. Reactive risk management addressing claims after they occur
  2. Disciplinary risk management through staff termination protocols
  3. Proactive risk management through system-level error prevention (correct answer)
  4. Regulatory risk management required by state board mandate
Explanation: Implementing barcode verification before dispensing is a proactive, system-level strategy designed to prevent errors before they reach the patient. Proactive risk management addresses root causes through process improvement and technology. Reactive management responds after harm occurs. Disciplinary responses address personnel, not system design. While boards may encourage such systems, the question asks about the strategy type.

Question 17

A plaintiff attorney argues that a pharmacy chain's policy of filling 20+ prescriptions per pharmacist per hour creates systemic malpractice risk. Which analysis BEST supports this argument?

  1. High volume is standard practice and does not establish liability as long as no errors occur
  2. Excessive workload reduces the time available for DUR, counseling, and verification, increasing the probability of dispensing errors and breaches of the standard of care (correct answer)
  3. Pharmacist productivity targets are outside the scope of malpractice claims
  4. Liability rests solely with the individual pharmacist, not the chain's staffing policies
Explanation: Excessive workload that prevents pharmacists from performing required clinical functions - DUR, counseling, verification - can constitute a systemic breach of the standard of care. Courts and licensing boards have recognized that unreasonable productivity demands that compromise safety create liability both for the individual pharmacist and, under respondeat superior, for the employer. Liability is not limited to the individual pharmacist when organizational policies create the conditions for error.

Question 18

What is the standard of care against which pharmacist conduct is measured in a malpractice case?

  1. The conduct of a physician managing the same patient
  2. The strictest possible adherence to all pharmacy laws and regulations
  3. The level of skill and care exercised by a reasonably prudent pharmacist under similar circumstances (correct answer)
  4. The conduct described in the pharmacy's internal standard operating procedures
Explanation: The legal standard of care in pharmacist malpractice cases is what a reasonably prudent pharmacist would do under the same or similar circumstances. This is typically established through expert witness testimony from practicing pharmacists. It is not judged by physician standards, absolute regulatory compliance, or a specific pharmacy's internal SOPs, though SOPs may be relevant evidence.

Question 19

A pharmacy technician makes a dispensing error that causes patient harm. The supervising pharmacist performed the final verification check but missed the error. How is liability MOST likely allocated?

  1. Liability rests solely with the technician since the technician made the physical error
  2. Liability rests solely with the prescriber for writing an unclear prescription
  3. Liability may fall on both the supervising pharmacist and the pharmacy employer. (correct answer)
  4. Liability is shared equally between the technician and the state board
Explanation: The pharmacist who performed the final verification bears professional responsibility for errors that a competent check should have caught. The pharmacy employer is vicariously liable under respondeat superior for errors committed by employees in the scope of their duties. The technician may also bear individual liability, but the pharmacist's failure to catch the error during verification constitutes an independent breach of duty. The state board adjudicates discipline; it does not share civil liability.

Question 20

Which of the following BEST describes the statute of limitations in a pharmacy malpractice case?

  1. The time period within which a plaintiff must file a malpractice lawsuit, as defined by state law (correct answer)
  2. The maximum dollar amount a plaintiff may recover in a malpractice action
  3. The minimum number of expert witnesses required to establish the standard of care
  4. The number of years a pharmacy must retain records in case of a future malpractice claim
Explanation: The statute of limitations is the legally defined window of time in which a plaintiff may file a lawsuit. In malpractice cases, this period varies by state and may begin running from the date of the negligent act, the date of discovery of harm, or when the patient-provider relationship ends. Failing to file within the statute of limitations typically bars the claim. The other options describe damage caps, expert witness rules, and record retention - distinct legal concepts.